Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152,309,909
-
Total 13F shares
-
36,254,970
-
Share change
-
-171,882
-
Total reported value
-
$8,982,485,029
-
Put/Call ratio
-
111%
-
Price per share
-
$247.73
-
Number of holders
-
409
-
Value change
-
-$42,929,390
-
Number of buys
-
196
-
Number of sells
-
170
Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q3 2020
As of 30 Sep 2020,
BIO-TECHNE Corp - COMMON STOCK (TECH) was held by
409 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,254,970 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, BROWN CAPITAL MANAGEMENT LLC, BAMCO INC /NY/, Neuberger Berman Group LLC, Jackson Square Partners, LLC, Champlain Investment Partners, LLC, DF DENT & CO INC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and STATE STREET CORP.
This page lists
409
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.